KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maxlinear (MXL) Research & Development (2016 - 2026)

Maxlinear has reported Research & Development over the past 17 years, most recently at $53.2 million for Q1 2026.

  • Quarterly Research & Development fell 4.14% to $53.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $206.3 million through Mar 2026, down 4.44% year-over-year, with the annual reading at $208.6 million for FY2025, 7.37% down from the prior year.
  • Research & Development was $53.2 million for Q1 2026 at Maxlinear, up from $51.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $80.4 million in Q2 2022 and troughed at $47.2 million in Q2 2025.
  • The 5-year median for Research & Development is $64.8 million (2024), against an average of $61.9 million.
  • Year-over-year, Research & Development grew 13.18% in 2022 and then decreased 21.41% in 2024.
  • A 5-year view of Research & Development shows it stood at $73.7 million in 2022, then fell by 11.49% to $65.2 million in 2023, then decreased by 21.41% to $51.3 million in 2024, then increased by 0.81% to $51.7 million in 2025, then rose by 2.85% to $53.2 million in 2026.
  • Per Business Quant, the three most recent readings for MXL's Research & Development are $53.2 million (Q1 2026), $51.7 million (Q4 2025), and $54.3 million (Q3 2025).